{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:41:44Z","timestamp":1794580904706,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41401-020-00582-4","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T15:41:10Z","timestamp":1611330070000},"page":"1665-1675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["BAFF, involved in B cell activation through the NF-\u03baB pathway, is related to disease activity and bone destruction in rheumatoid arthritis"],"prefix":"10.1038","volume":"42","author":[{"given":"Ling-ling","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ling","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"582_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cyto.2015.07.014","volume":"76","author":"F Wei","year":"2015","unstructured":"Wei F, Chang Y, Wei W. The role of BAFF in the progression of rheumatoid arthritis. Cytokine. 2015;76:537\u201344.","journal-title":"Cytokine"},{"key":"582_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/annrheumdis-2012-202775","volume":"72","author":"MC Genovese","year":"2013","unstructured":"Genovese MC, Fleischmann RM, Greenwald M, Satterwhite J, Veenhuizen M, Xie L, et al. Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. Ann Rheum Dis. 2013;72:1461\u20138.","journal-title":"Ann Rheum Dis"},{"key":"582_CR3","first-page":"349","volume":"8","author":"A Shetty","year":"2014","unstructured":"Shetty A, Hanson R, Korsten P, Shawagfeh M, Arami S, Volkov S, et al. Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Dev Ther. 2014;8:349\u201364.","journal-title":"Drug Des Dev Ther"},{"key":"582_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/art.23824","volume":"59","author":"LL Zhang","year":"2008","unstructured":"Zhang LL, Wei W, Xiao F, Xu JH, Bao CD, Ni LQ, et al. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis. Arthritis Rheum. 2008;59:905\u201310.","journal-title":"Arthritis Rheum"},{"key":"582_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15\u201325.","journal-title":"Arthritis Rheum"},{"key":"582_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.berh.2009.11.006","volume":"24","author":"SB Cohen","year":"2010","unstructured":"Cohen SB. Targeting the B cell in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010;24:553\u201363.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"582_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar3908","volume":"15","author":"MJ Leandro","year":"2013","unstructured":"Leandro MJ. B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther. 2013;15:S3.","journal-title":"Arthritis Res Ther"},{"key":"582_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biocel.2009.10.011","volume":"42","author":"E Nashi","year":"2010","unstructured":"Nashi E, Wang Y, Diamond B. The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol. 2010;42:543\u201350.","journal-title":"Int J Biochem Cell Biol"},{"key":"582_CR9","first-page":"217593","volume":"2015","author":"JF Rossi","year":"2015","unstructured":"Rossi JF. Targeted therapies in adult B-cell malignancies. BioMed Res Int. 2015;2015:217593.","journal-title":"BioMed Res Int"},{"key":"582_CR10","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.4049\/jimmunol.177.6.3728","volume":"177","author":"JF Fecteau","year":"2006","unstructured":"Fecteau JF, Cote G, Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol. 2006;177:3728\u201336.","journal-title":"J Immunol"},{"key":"582_CR11","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1182\/blood-2011-04-345579","volume":"118","author":"MA Berkowska","year":"2011","unstructured":"Berkowska MA, Driessen GJ, Bikos V, Grosserichter-Wagener C, Stamatopoulos K, Cerutti A, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 2011;118:2150\u20138.","journal-title":"Blood"},{"key":"582_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/BOR.0000000000000000","volume":"26","author":"T Dorner","year":"2014","unstructured":"Dorner T, Lipsky PE. B cells: depletion or functional modulation in rheumatic diseases. Curr Opin Rheumatol. 2014;26:228\u201336.","journal-title":"Curr Opin Rheumatol"},{"key":"582_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.molimm.2011.03.014","volume":"48","author":"B cells and autoimmunity 2010.","year":"2011","unstructured":"B cells and autoimmunity 2010. Proceedings of a conference. August 2010. Nara, Japan. Mol Immunol. 2011;48:1279\u2013347.","journal-title":"Mol Immunol"},{"key":"582_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1759720X15586782","volume":"7","author":"SA Morais","year":"2015","unstructured":"Morais SA, Vilas-Boas A, Isenberg DA. B-cell survival factors in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis. 2015;7:122\u201351.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"582_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.it.2011.06.004","volume":"32","author":"Z Liu","year":"2011","unstructured":"Liu Z, Davidson A. BAFF and selection of autoreactive B cells. Trends Immunol. 2011;32:388\u201394.","journal-title":"Trends Immunol"},{"key":"582_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.smim.2006.04.005","volume":"18","author":"F Mackay","year":"2006","unstructured":"Mackay F, Leung H. The role of the BAFF\/APRIL system on T cell function. Semin Immunol. 2006;18:284\u20139.","journal-title":"Semin Immunol"},{"key":"582_CR17","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1073\/pnas.97.7.3370","volume":"97","author":"SD Khare","year":"2000","unstructured":"Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I, et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA. 2000;97:3370\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44:1313\u20139.","journal-title":"Arthritis Rheum"},{"key":"582_CR19","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3899\/jrheum.121110","volume":"40","author":"RA Moura","year":"2013","unstructured":"Moura RA, Canhao H, Polido-Pereira J, Rodrigues AM, Navalho M, Mourao AF, et al. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis. J Rheumatol. 2013;40:1293\u2013302.","journal-title":"J Rheumatol"},{"key":"582_CR20","first-page":"1256","volume":"35","author":"S Bosello","year":"2008","unstructured":"Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, et al. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol. 2008;35:1256\u201364.","journal-title":"J Rheumatol"},{"key":"582_CR21","doi-asserted-by":"publisher","first-page":"15517","DOI":"10.1073\/pnas.0807841105","volume":"105","author":"JL Scholz","year":"2008","unstructured":"Scholz JL, Crowley JE, Tomayko MM, Steinel N, O\u2019Neill PJ, Quinn WJ 3rd, et al. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci USA. 2008;105:15517\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jep.2012.02.034","volume":"141","author":"PP Li","year":"2012","unstructured":"Li PP, Liu DD, Liu YJ, Song SS, Wang QT, Chang Y, et al. BAFF\/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin. J Ethnopharmacol. 2012;141:290\u2013300.","journal-title":"J Ethnopharmacol"},{"key":"582_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9:491\u2013502.","journal-title":"Nat Rev Immunol"},{"key":"582_CR24","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.4049\/jimmunol.0800933","volume":"183","author":"WN Khan","year":"2009","unstructured":"Khan WN. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J Immunol. 2009;183:3561\u20137.","journal-title":"J Immunol"},{"key":"582_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1111\/j.1582-4934.2009.00817.x","volume":"14","author":"H Ding","year":"2010","unstructured":"Ding H, Wang L, Wu X, Yan J, He Y, Ni B, et al. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med. 2010;14:1717\u201325.","journal-title":"J Cell Mol Med"},{"key":"582_CR26","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/ni.1666","volume":"9","author":"JE Stadanlick","year":"2008","unstructured":"Stadanlick JE, Kaileh M, Karnell FG, Scholz JL, Miller JP, Quinn WJ 3rd, et al. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol. 2008;9:1379\u201387.","journal-title":"Nat Immunol"},{"key":"582_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.immuni.2004.09.011","volume":"21","author":"AP Grech","year":"2004","unstructured":"Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity. 2004;21:629\u201342.","journal-title":"Immunity"},{"key":"582_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.01.009","volume":"28","author":"S Gardam","year":"2008","unstructured":"Gardam S, Sierro F, Basten A, Mackay F, Brink R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity. 2008;28:391\u2013401.","journal-title":"Immunity"},{"key":"582_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.immuni.2004.09.011","volume":"21","author":"AP Grech","year":"2004","unstructured":"Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity. 2004;21:629\u201342.","journal-title":"Immunity"},{"key":"582_CR30","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood-2007-03-081232","volume":"111","author":"G Badr","year":"2008","unstructured":"Badr G, Borhis G, Lefevre EA, Chaoul N, Deshayes F, Dessirier V, et al. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood. 2008;111:2744\u201354.","journal-title":"Blood"},{"key":"582_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"582_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0064-y","volume":"16","author":"N Zheng","year":"2015","unstructured":"Zheng N, Wang D, Ming H, Zhang H, Yu X. BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R. BMC Nephrol. 2015;16:72.","journal-title":"BMC Nephrol"},{"key":"582_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11926-004-0008-1","volume":"6","author":"SL Bridges","year":"2004","unstructured":"Bridges SL. Update on autoantibodies in rheumatoid arthritis. Curr Rheumatol Rep. 2004;6:343\u201350.","journal-title":"Curr Rheumatol Rep"},{"key":"582_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/aps.2016.15","volume":"37","author":"F Zhang","year":"2016","unstructured":"Zhang F, Song SS, Shu JL, Li Y, Wu YJ, Wang QT, et al. BAFF upregulates CD28\/B7 and CD40\/CD154 expression and promotes mouse T and B cell interaction in vitro via BAFF receptor. Acta Pharmacol Sin. 2016;37:1101\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"582_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/08820139.2013.879172","volume":"43","author":"SS Song","year":"2014","unstructured":"Song SS, Yuan PF, Chen JY, Fu JJ, Wu HX, Lu JT, et al. TGF-beta favors bone marrow-derived dendritic cells to acquire tolerogenic properties. Immunol Invest. 2014;43:360\u20139.","journal-title":"Immunol Invest"},{"key":"582_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2015.09.036","volume":"769","author":"Y Li","year":"2015","unstructured":"Li Y, Sheng K, Chen J, Wu Y, Zhang F, Chang Y, et al. Regulation of PGE2 signaling pathways and TNF-alpha signaling pathways on the function of bone marrow-derived dendritic cells and the effects of CP-25. Eur J Pharmacol. 2015;769:8\u201321.","journal-title":"Eur J Pharmacol"},{"key":"582_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","volume":"12","author":"F Hiepe","year":"2016","unstructured":"Hiepe F, Radbruch A. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nat Rev Nephrol. 2016;12:232\u201340.","journal-title":"Nat Rev Nephrol"},{"key":"582_CR38","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/art.22019","volume":"54","author":"P Roll","year":"2006","unstructured":"Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP. Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum. 2006;54:2377\u201386.","journal-title":"Arthritis Rheum"},{"key":"582_CR39","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.semarthrit.2015.08.001","volume":"45","author":"BK Han","year":"2016","unstructured":"Han BK, Olsen NJ, Bottaro A. The CD27-CD70 pathway and pathogenesis of autoimmune disease. Semin Arthritis Rheum. 2016;45:496\u2013501.","journal-title":"Semin Arthritis Rheum"},{"key":"582_CR40","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.4049\/jimmunol.172.12.7432","volume":"172","author":"Y Xiao","year":"2004","unstructured":"Xiao Y. HendriksJ, LangerakP, Jacobs H, Borst J. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J Immunol. 2004;172:7432\u201341.","journal-title":"J Immunol"},{"key":"582_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.coi.2011.01.006","volume":"23","author":"K Chen","year":"2011","unstructured":"Chen K, Cerutti A. The function and regulation of immunoglobulin D. Curr Opin Immunol. 2011;23:345\u201352.","journal-title":"Curr Opin Immunol"},{"key":"582_CR42","doi-asserted-by":"publisher","first-page":"e0147788","DOI":"10.1371\/journal.pone.0147788","volume":"11","author":"Y Wu","year":"2016","unstructured":"Wu Y, Chen W, Chen H, Zhang L, Chang Y, Yan S, et al. The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis. PLoS One. 2016;11:e0147788.","journal-title":"PLoS One"},{"key":"582_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1600-065X.2010.00942.x","volume":"237","author":"TD Chan","year":"2010","unstructured":"Chan TD, Gardam S, Gatto D, Turner VM, Silke J, Brink R. In vivo control of B-cell survival and antigen-specific B-cell responses. Immunol Rev. 2010;237:90\u2013103.","journal-title":"Immunol Rev"},{"key":"582_CR44","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/art.22697","volume":"56","author":"LK Assi","year":"2007","unstructured":"Assi LK, Wong SH, Ludwig A, Raza K, Gordon C, Salmon M, et al. Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint. Arthritis Rheum. 2007;56:1776\u201386.","journal-title":"Arthritis Rheum"},{"key":"582_CR45","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1756-185X.2012.01814.x","volume":"15","author":"Y Geng","year":"2012","unstructured":"Geng Y, Zhang ZL. Comparative study on the level of B lymphocyte stimulator (BlyS) and frequency of lymphocytes between sero-negative and sero-positive rheumatoid arthritis patients. Int J Rheum Dis. 2012;15:478\u201385.","journal-title":"Int J Rheum Dis"},{"key":"582_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/annrheumdis-2011-200379","volume":"71","author":"M van den Broek","year":"2012","unstructured":"van den Broek M, Dirven L, Klarenbeek NB, Molenaar TH, Han KH, Kerstens PJ, et al. The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study. Ann Rheum Dis. 2012;71:245\u20138.","journal-title":"Ann Rheum Dis"},{"key":"582_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13075-016-1116-9","volume":"18","author":"S Bugatti","year":"2016","unstructured":"Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther. 2016;18:226.","journal-title":"Arthritis Res Ther"},{"key":"582_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jbspin.2012.03.008","volume":"80","author":"A Omar","year":"2013","unstructured":"Omar A, Abo-Elyoun I, Hussein H, Nabih M, Atwa H, Gad S, et al. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). Joint Bone Spine. 2013;80:38\u201343.","journal-title":"Joint Bone Spine"},{"key":"582_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coi.2014.08.001","volume":"31","author":"LC Wu","year":"2014","unstructured":"Wu LC, Scheerens H. Targeting IgE production in mice and humans. Curr Opin Immunol. 2014;31:8\u201315.","journal-title":"Curr Opin Immunol"},{"key":"582_CR50","first-page":"18","volume":"19","author":"V Pavlovic","year":"2014","unstructured":"Pavlovic V, Dimic A, Milenkovic S, Krtinic D. Serum levels of IL-17, IL-4, and INFgamma in Serbian patients with early rheumatoid arthritis.\u00a0J Res Med Sci.\u00a02014;19:18\u201322.","journal-title":"J Res Med Sci"},{"key":"582_CR51","first-page":"28","volume":"92","author":"AS Avdeev","year":"2014","unstructured":"Avdeev AS, Novikov AA, Aleksandrova EN, Panasiuk E, Nasonov EL. [The importance of cytokine profile characteristics for evaluating the therapeutic effectiveness of monoclonal antibodies against IL-6 receptors in patients with rheumatoid arthritis]. Klin Med (Mosk). 2014;92:28\u201334.","journal-title":"Klin Med (Mosk)"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00582-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00582-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T11:37:59Z","timestamp":1634038679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00582-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00582-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"29 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}